WZ811 50 mg | 99.93%
TargetMol
WZ811 is a novel and effective small molecular CXCR4 antagonist (EC50: 0.3 nM).
More Information Supplier Page
WZ811 is a novel and effective small molecular CXCR4 antagonist (EC50: 0.3 nM).
More Information Supplier Page
Varenicline tartrate is a benzazepine derivative that functions as an ALPHA4/BETA2 NICOTINIC RECEPTOR partial agonist. It is used for SMOKING CESSATION.
More Information Supplier Page
Varenicline tartrate is a benzazepine derivative that functions as an ALPHA4/BETA2 NICOTINIC RECEPTOR partial agonist. It is used for SMOKING CESSATION.
More Information Supplier Page
Nateglinide is an oral hypoglycemic agent and amino acid derivative that stimulates insulin secretion from the pancreas and is used in the therapy of type 2 diabetes. Nateglinide has been linked to rare instances of clinically apparent acute liver injury.
More Information Supplier Page
Nateglinide is an oral hypoglycemic agent and amino acid derivative that stimulates insulin secretion from the pancreas and is used in the therapy of type 2 diabetes. Nateglinide has been linked to rare instances of clinically apparent acute liver injury.
More Information Supplier Page
Montelukast sodium is an orally available leukotriene receptor antagonist which is widely used for the prophylaxis and chronic treatment of asthma.
More Information Supplier Page
Montelukast sodium is an orally available leukotriene receptor antagonist which is widely used for the prophylaxis and chronic treatment of asthma.
More Information Supplier Page
Aminophylline is a competitive nonselective phosphodiesterase inhibitor giving a bronchodilatory effect.
More Information Supplier Page
Aminophylline is a competitive nonselective phosphodiesterase inhibitor giving a bronchodilatory effect.
More Information Supplier Page
Enalapril IMpurity B ((+)-N-[1-(S)-Ethoxycarbonxyl-3-phenylpropyl]-L-alanine) is Moexipril intermediate and is the main metabolite of Imidapril.
More Information Supplier Page